Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)
Clinical trial NCT05770882 · TERMINATED
Trial details
- NCT number
- NCT05770882
- Sponsor
- Great Novel Therapeutics Biotech & Medicals Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2025-01-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.